VANI vs. BWAY, SMTI, SI, OM, MGRM, NNOX, TLSI, CVRX, INGN, and CV
Should you be buying Vivani Medical stock or one of its competitors? The main competitors of Vivani Medical include Brainsway (BWAY), Sanara MedTech (SMTI), Shoulder Innovations (SI), Outset Medical (OM), Monogram Orthopaedics (MGRM), Nano-X Imaging (NNOX), TriSalus Life Sciences (TLSI), CVRx (CVRX), Inogen (INGN), and CapsoVision (CV). These companies are all part of the "medical equipment" industry.
Vivani Medical vs. Its Competitors
Brainsway (NASDAQ:BWAY) and Vivani Medical (NASDAQ:VANI) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, media sentiment, valuation, dividends, earnings, institutional ownership and analyst recommendations.
Brainsway has a net margin of 11.60% compared to Vivani Medical's net margin of 0.00%. Brainsway's return on equity of 8.97% beat Vivani Medical's return on equity.
Brainsway presently has a consensus target price of $18.00, indicating a potential upside of 12.50%. Vivani Medical has a consensus target price of $4.00, indicating a potential upside of 203.03%. Given Vivani Medical's higher probable upside, analysts clearly believe Vivani Medical is more favorable than Brainsway.
Brainsway has a beta of 1.23, indicating that its stock price is 23% more volatile than the S&P 500. Comparatively, Vivani Medical has a beta of 3.18, indicating that its stock price is 218% more volatile than the S&P 500.
In the previous week, Brainsway had 2 more articles in the media than Vivani Medical. MarketBeat recorded 5 mentions for Brainsway and 3 mentions for Vivani Medical. Brainsway's average media sentiment score of 0.63 beat Vivani Medical's score of 0.62 indicating that Brainsway is being referred to more favorably in the media.
30.1% of Brainsway shares are owned by institutional investors. Comparatively, 6.8% of Vivani Medical shares are owned by institutional investors. 19.0% of Brainsway shares are owned by company insiders. Comparatively, 46.4% of Vivani Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Brainsway has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks.
Summary
Brainsway beats Vivani Medical on 12 of the 15 factors compared between the two stocks.
Get Vivani Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for VANI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding VANI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vivani Medical Competitors List
Related Companies and Tools
This page (NASDAQ:VANI) was last updated on 10/15/2025 by MarketBeat.com Staff
